US Patent 10155044 Methods and compositions for deterring abuse
Patent 10155044 was granted and assigned to Acura Pharmaceuticals on December, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+597 characters)
Article
Patent abstract
Effective methods and compositions to deter abuse of pharmaceutical products (e.g., orally administered pharmaceutical products) including but not limited to immediate release, sustained or extended release and delayed release formulations for drugs subject to abuse comprising at least 10% by weight hydroxypropylcellulose; polyethylene oxide; and a disintegrant selected from the group consisting of crospovidone, sodium starch glycolate and croscarmellose sodium; wherein the ratio of hydroxypropylcellulose to polyethylene oxide on a weight basis is between about 10:1 and 1:10.
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Albert W. Brzeczko0
Rachelle L. Hall Yung0
Ronald L. Leech0
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
101550440
Date of Patent
December 18, 2018
0Patent Application Number
154262960
Date Filed
February 7, 2017
0Patent Primary Examiner
Edits on 24 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10155044 Methods and compositions for deterring abuse
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10155044
Date of patent
December 18, 2018
Patent application number
15426296
Date Filed
February 7, 2017
Patent primary examiner
Find more entities like US Patent 10155044 Methods and compositions for deterring abuse
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.